Search results
Alzheimer's disease processes without symptoms. How is that possible?
Medical Xpress· 6 hours agoEveryone experiences aging in their own way, and factors such as genetics, lifestyle and environment play a role in this process. Some individuals reach the age of 90 or even 100 in good health ...
New biomarker identified to diagnose Alzheimer's in asymptomatic stages
Medical Xpress· 11 hours agoMolecular Basis of Disease. The search for biomarkers that are stable and easily detectable in...
The Stages of Dementia, Explained
Health.com· 5 days agoThe most common cause of dementia is Alzheimer’s disease. Unfortunately, dementia is progressive, meaning it worsens over time. Over ...
Lisa Jarvis: Would you get tested for an Alzheimer’s gene?
Napa Valley Register· 3 days agoIn a new paper in "Nature Medicine," an international team of neurologists makes the compelling case...
A gene long thought to just raise the risk for Alzheimer's may cause some cases
Casper Star-Tribune· 6 days agoFor the first time, researchers have identified a genetic form of late-in-life Alzheimer's disease.
LIVING WELL: New drug approved to treat Alzheimer’s Disease
FOX 16 Little Rock· 2 days agoThe FDA approved a new drug to treat Alzheimer’s Disease.
What is the first thing a person with Alzheimer's forgets?
CCM· 3 days agoAccording to experts these are the first signs of Alzheimer's disease. The National Institute on...
Pumping iron has surprising cognitive rewards, study finds
The Washington Times· 4 hours agoPeople who exercise have a lower risk of brain disorders such asAlzheimer’s disease and depression,...
This woman has ALS. So did 22 of her relatives. What she wants you to know.
USA TODAY via Yahoo News· 12 hours agoNow, Morris' optimism shines through a video call as she recalls her doctor's words: "She hopes for...
AlzeCure Reports Anti-Inflammatory Effects with NeuroRestore ACD856 with Relevance to Alzheimer's...
Digital Journal· 3 days ago...Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company has received preclinical data for NeuroRestore in...